Tootfinder

At a hearing last week, members of the "Senate Special Committee on Aging" criticized generic drug manufacturers
for routinely concealing the locations of their drugmaking plants
as well as the suppliers that provide key ingredients.
ProPublica described this lack of transparency — and how it was enabled by the Food and Drug Administration — in a series of stories that found
the agency had quietly allowed troubled foreign drugmakers to continue selling gene…

The Clear Labels Act Would Change What You Know About Your Prescription Medication
The bill, introduced by Sens. Rick Scott and Kirsten Gillibrand, follows a bipartisan investigation that cited ProPublica’s reporting on dangerous foreign drugmakers and the medicine they continued to sell in the U.S.